MedPath

Prospective diagnosis of Covid-19 infection using exhaled breath analysis by electronic nose

Recruiting
Conditions
acute respiratory tract infection
flu
10024970
Registration Number
NL-OMON54883
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10300
Inclusion Criteria

acute respiratory tract infection, COVID-19 infection

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded
from participation in this study:
- Recent (< 12 hours) intake of alcohol
- Unwillingness or inability to comply with the study protocol for any other
reason
In order to increase the applicability in clinical practice, there are no
further restrictions.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Main study parameters/endpoints:<br /><br>Exhaled breath profiles obtained by sampling exhaled air using real time eNose<br /><br>technology to determine COVID-19 infection</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To assess the accuracy of exhaled breath analysis by eNose at baseline for<br /><br>discrimination between individuals with different disease progression (e.g.<br /><br>mild respiratory symptoms, ICU admission and death). </p><br>
© Copyright 2025. All Rights Reserved by MedPath